Discovery of Potent Allosteric DRP1 Inhibitors by Disrupting Protein-Protein Interaction with MiD49

  • ACS Med Chem Lett. 2023 Jul 24;14(8):1095-1099. doi: 10.1021/acsmedchemlett.3c00223.
Takeru Furuya  1 Jean Lin  1 Arina Afanaseva  1 Lisa Molz  1 Bharat Lagu  1 Bin Ma  1
Affiliations
  • 1. Mitobridge, Inc., an Astellas Company, Cambridge, Massachusetts 02138, United States.
Abstract

Mitochondrial dysfunction has been attributed to many disease indications, including metabolic, cardiovascular, neoplastic, and neurodegenerative diseases. Dynamin related protein 1 (DRP1) is crucial in regulating mitochondrial fission and maintaining mitochondrial homeostasis. MiD49 is a dynamic peripheral protein receptor on the surface of the mitochondrial membrane that recruits DRP1 protein to induce mitochondrial binary fission. By targeting the protein-protein interaction of DRP1/MiD49, we have discovered a novel and potent allosteric DRP1 inhibitor that inhibits mitochondria fragmentation in vitro. X-ray cocrystal structure revealed that it locked the closed DRP1 conformation by induced dimerization.

Products